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ABSTRACT 
 
 
 
This work examines consumer awareness of soy, including which information source enabled 
consumers to form their beliefs regarding soy's health implications.  Controversy surrounds 
the much-researched topic of soy, including its isolated compounds, processing and 
manufacturing methods, seed source, and consumption amounts.  Inconsistent results in 
research lead to disagreements on what is and what is not safe, and for whom.  Participants in 
six states were recruited from a convenience sample and asked to complete a seven-question 
survey. Results indicate a great amount of uncertainty with consumers regarding whether soy 
is beneficial or detrimental, especially when considering the prevalence of internet soy fear 
mongering. In order for consumers to feel confident in consuming soy foods and sharing 
them with their families, future studies must resolve questions surrounding genetically 
modified organisms (GMO) and hexane processed soy and arm consumers and educators 
with recent and reliable soy health information. 
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Chapter 1:  Overview of Study 
 
Introduction – Statement of Problem 
 
With more than 2,000 peer-reviewed journal articles published each year relating to 
soy, health professionals have volumes of credible information to stay continuously updated.  
However, the controversy over soy and disease leaves some health practitioners and 
consumers uneasy.  Unanswered questions surround research, such as is lifetime exposure a 
key factor (1) as to why soy's phytoestrogens can act as an estrogen antagonist or agonist (2), 
or is it the fact that some people are equol producers (3) and some aren't?  Some research 
states that the protective effects of soy are only realized while consuming whole soy foods 
(4), yet other studies assert it is the isoflavone that is protective (5).  Additional studies 
maintain that fermented is more protective than nonfermented soy (6). Some researchers use 
the same amounts of soy in their research as Asians traditionally consume in their everyday 
diet, while others employ amounts of soy protein or isolates in their research that are 
impossible to achieve through daily dietary measures (3). The confounding results of recent 
studies create polarizing views regarding soy's role in regard to cancer, heart disease, weight 
management, thyroid health, and fertility. 
Questions also arise as to the quality of the soy and its bioactive constituents that is 
being used in research, as well as whether soy's protective effect occurs only in 
premenopausal versus postmenopausal women, or vice versa. In addition, over the past two 
years the safety of genetically modified soy and soy processed with hexane has been brought 
to consumers' attention.  Other major concerns today relate to whether soy is safe for infants, 
children, and breast cancer survivors.   
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Questioning the safety of soy first occurred to the author when her daughter needed to 
supplement breast milk for her then 10-month-old daughter. Being from a family with 
notorious dairy allergies, the author researched the possibility of the mother using organic 
soy infant formula and was satisfied the infant would clearly derive health benefits over cow 
milk-based formula.  However, the intensity of the controversy over soy was brought to the 
author's attention following an incident her daughter experienced with a stranger upon 
leaving a health food store after buying organic soy infant formula.  The woman followed her 
through the parking lot claiming she was killing her child by feeding her soy formula, 
demanding that she return the formula, and labeling her an unfit mother if she didn't.  
Other instances brought soy's controversy to the author's attention when clients 
became adamant about soy's dangers after soymilk or tofu was mentioned as a high-quality 
protein in a nutritional consultation.  Furthermore, while teaching across the United States, 
the author has seen followers of the Weston A. Price Foundation become agitated, shout out, 
and even storm away from a meeting if soy is mentioned as having health benefits.    
 Soybeans have been a staple food for the Chinese for more than 5,000 years, and its 
use as a high-quality protein food slowly spread across Korea, Japan, India, Europe and 
America (7). The low incidences of prostate and breast cancer in China, fueled by the low 
rates of heart disease in Japan, piqued interest in the 1990s when researchers began to 
consider the idea that soy and its constituents held properties for preventing chronic disease 
(8).  Around the same time, the United States National Cancer Institute sponsored research 
on soy, and results indicated that soy possessed an ability to lower cholesterol, inhibit bone 
loss, and reduce hot flashes (9). 
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Significance and Purpose of Study 
This research is significant to the discipline of nutrition.  Nutritionists are educators, 
and educators must convey accurate and timely information on soy to clear away any 
misconceptions among patients and the public.  Therefore, this thesis examines the 
consumers' awareness of soy, including which information source was referenced to enable 
one to form a personal belief regarding the safety of soy.  The author's hope is that, from the 
results of this study, nutritionists, clinicians, health professionals, and educators will  
• receive access to accurate and up-to-date information on the latest soy research,  
• gain a better understanding of what patients and consumers believe about soy, and 
 • learn whether their sources for information are credible. 
The greater goal is to help the public make the best choice possible for their long-term health. 
 Voluntary participants in this study were procured from a convenience sample of 
individuals from across the country who attended day-long seminars on herbal medicine and 
nutrition between August 26 and November 4, 2011.  Participants included a small number of 
health professionals; however, the vast majority had never before attended a health class.  
Participants were asked to complete a seven-question survey.  
	 4
Chapter 2:  Review of Literature 
 
 
History of Soy Research 
 
 The scientific community has been researching soy since the 1940s when attention 
was drawn to infertility issues in sheep grazing on red clover.  It wasn't until the 1950s that 
researchers discovered that the estrogenic isoflavones in soy could function as both an anti-
estrogen and a growth promoter for the animal feed industry.  In 1995 soy protein studies 
indicated that these estrogenic isoflavones could be an alternative to conventional hormone 
replacement therapy (9) and research on soy exploded, with a focus on Asians and their soy 
consumption patterns.  
 In 1999 the United Nations Food and Agriculture Organization (FAO) recorded that 
North Koreans consumed up to 9.6 grams of soy per day, followed by the Japanese (8.7 gr), 
Indonesians (7.4 gr), South Koreans (6.5 gr), and Chinese (5.1 gr).  Just four years later, in 
2003, the FAO recorded that Chinese consumption had dropped to 3.4 grams per capita, 
while all other nations either increased their soy consumption slightly or remained the same. 
Europeans and Americans ate <1 gram of soy protein per day consistently (10). Interestingly, 
the incidence of breast cancer continued to increase in the East Asian countries of China, 
Japan, and Korea, as their dietary habits changed and they began to adopt a Western diet 
(11).  Ordinarily prone to stomach, esophageal, and liver cancer, when Chinese adopted a 
Western diet they became susceptible to heart attacks and other cancers as well (12).  
 Results for the connection between cancer and soy food consumption have been 
inconsistent when comparing U.S. and Asian-based cohorts.  Reasons include differing 
amounts of long-term consumption and types of soy foods ingested (12). Research is linking 
high soy intake early in life with reduced risk of premenopausal breast cancer later in life; 
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and while Asians consume soy over their lifetime, Westerners may not begin ingesting soy 
until adulthood (13).   
 
Consumption Patterns 
 A recent article in the Journal of the American Medical Association suggests 10% or 
more of Asian's daily protein intake comes from soy, with an average intake of isoflavones at 
45-50 mg/d, compared to <1-6 mg/d of isoflavones in Western populations (14,15).  Some 
researchers calculate that Asian diets contain levels of 10-25 mg of isoflavones per day (16), 
with the mean dietary intake of soy foods in Chinese women being approximately 7.36 gr/d 
(12).  Studies show that up to 50 mg of isoflavones daily has little impact on circulating 
hormone levels although >100 mg can reduce the functioning of the ovaries, and 150 mg can 
significantly increase the occurrence of endometrial hyperplasia in non-Asian women (16). 
 The Asian diet is highlighted by fermented soy foods, such as miso, natto, sufu, 
tempeh, douchi, and soy sauce (12).  According to an article published in Cancer Science 
earlier this year, researchers conducted a study on gastric cancer patients where results 
demonstrated that consuming fermented soy foods was significantly associated with an 
increased risk, whereas nonfermented soy decreased the risk.  This could explain the reason 
for the high incidence of gastric cancer in the Korean and Japanese populations due to their 
high intake of fermented foods (6).   
 In a prostate cancer study published last year in Urology, chemoprotective properties 
were significantly observed with a reduction in risk in Asian men when nonfermented soy 
was used, yet fermented soy did not have the same effect.  However, soy had no effect on the 
prostate-specific antigen (PSA) levels of Western men or those already possessing healthy 
prostates whether fermented or nonfermented soy was used (5).    
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 In the United States, tofu and soy protein isolates are substituted for animal meats 
(12).  Asian soy consumers focus on whole soy foods such as edamame, cooked soybeans, 
and soy milk, whereas American soy consumers focus on soy supplements (15) and 
processed foods containing defatted soy protein in the form of frozen soy desserts, soy infant 
formula, and soy cheese (10).  In addition, Americans enjoy meat substitutes processed with 
added soy compounds or soy protein isolates (15).  Meat substitutes made from soy were 
developed by scientists employed by Henry Ford during the Great Depression and come in 
the form of vegetarian chicken, sausage, steaks, lunchmeats, burgers, hot dogs, and bacon 
bits.  Other uses of whole or defatted soy protein can be found extending meat in schools, 
enhancing cereals and energy bars, and as a base in protein-fortified weight loss drinks (10).  
However, the United States Food and Drug Administration's (FDA) claim that "25 grams of 
soy protein a day, as part of a diet low in saturated fat and cholesterol, may reduce the risk of 
heart disease" does not extend to isolated soy components (12).    
 
Soy Isoflavones 
 Isoflavones are abundant in soy products, and their distribution and content can 
greatly vary in different parts of the soybean. The three types of isoflavones that are abundant 
in soy, in order of proportion, are genistein (50-55% of the total isoflavone content in soy), 
daidzein (40-45%), and glycitein (5-10%) (3,17). Isoflavones exist in soy in the form of 
aglycones.  These isoflavone types are present in three chemical forms: acetylglucosides, 
malonylglucosides, and the glucosides genistin, daidzin, and glycitin (14,18). The germ coat 
is high in glycitin and daidzin while the cotyledon, which forms the leaf, contains the largest 
amount of genistin and daidzin.  The germ holds the greatest amount of the antioxidant value 
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in the soybean seed (19).  Depending on the manufacturing process, the content of 
isoflavones can range from .3 mg to 5.5 mg per gram of protein (14).  
 Isoflavones structurally resemble estrogen (5) and can bind to estrogen receptor sites, 
thereby inhibiting the action and biological availability of natural estrogen. Further, 
isoflavones can reduce the body's estrogen production and increase clearance from 
circulation (14) to inhibit the growth of estrogen-dependent cancer cells (2,13,20).  The 
isoflavone genistein has a greater affinity for beta cells than alpha cells by 7-30 fold (3) and 
can act as an estradiol in target tissues (21).  Genistein has been shown to inhibit cell growth 
in prostate cancer (5). 
 Phytoestrogens are thousands of times less potent than endogenous estrogen (2), and 
even the potency of xenobiotic estrogens is low in comparison to endogenous estrogen (3).  
The structure of these plant estrogens allows them to bind to both beta and alpha-receptor 
sites, and, depending on the level of biologically produced estrogen, phytoestrogens can act 
as an estrogen antagonist or agonist (2).  
 In the peer-reviewed journal, Nutrition for the Family, author K. H. Morin reports 
that research surrounding soy's estrogenic effect on males regarding fertility and feminization 
indicates that neither soy foods nor supplements negatively affect reproductive health or 
testosterone levels (22).  Nor does it appear that soy protein isolates adversely affect semen 
volume, count, motility, or concentration (23).  In addition, reports indicate that soy protein 
substantially lowers the risk of ovulatory infertility in women (22) along with endometrial 
and ovarian cancers (24).  
 A study published by the American Journal of Clinical Nutrition in 2010 questioned 
whether the protective effect of soy on breast cancer in Asian populations was due to isolated 
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soy isoflavones, a combination of soy isoflavones, or a combination of soy and other dietary 
factors (25) such as their high consumption of fruits and vegetables (12).  Inconsistent results 
in studies targeting isolated soy components or processed soy foods have researchers 
believing their focus should be on traditional whole soy foods (4).  
 The Australian Journal of Herbal Medicine published a study in 2011 indicating that 
when isoflavones were combined, they did not affect tumor growth; however, diadzein alone 
increased lung and heart metastases and increased mammary tumors by 38%, while genistein 
alone was able to decrease bone and liver metastases, as well as decrease mammary tumors 
by 33% (3,26).  A recent study conducted on soy and reported in the Journal of Integrative 
Biology indicated that soy extract hastened apoptosis in in-vitro studies more significantly 
than genistein or daidzein alone, suggesting that whole soy foods are more tumor cell-
specific and chemoprotective than isolated compounds (27). 
 
Animal Studies with Soy 
 An animal study published in 2009 in the International Journal of Biotechnology and 
Biochemstry demonstrates that soy-enriched pet food does not negatively affect hormone 
levels in animals (18), while other studies reported in the Society of Gynecologic Nurse 
Oncologists journal reveal an increase in breast tumor growth when refined soy products are 
fed to animals (2).  In mice implanted with tumors, inconsistent outcomes suggest the results 
depend upon the isoflavone preparation used as reported last year in Nutrition Review (14).  
 The results of animal studies remain questionable in their relevance to humans due to 
the use of parenteral doses of purified isoflavones that are 8 to 16 times greater than that 
found in the typical Asian diet.  Additionally, it is speculated that 95% of the isoflavones in 
humans are essentially inactive; and while the diadzein metabolite equol prevails in rodents, 
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only 30-50% of humans are equol producers (3). Equol binds more easily to estrogen 
receptors than does its precursor daidzein (28).  
  
Body Composition and Weight 
 According to BMC Neuroscience, parenteral equol in animal studies conducted in 
2011 demonstrated a significant decrease in body weight, white adipose fat tissue, and 
depressive-related behavior (29).  Human studies find a mildly favorable effect on body 
composition in postmenopausal women when 15 gr of soy protein or 100 mg of soy 
isoflavones daily were consumed over a six-month period (30).  A study with menopausal 
women showed a 7.5% reduction in total abdominal fat and a 9.1% decrease in subcutaneous 
abdominal fat when 20 grams of soy protein and 160 milligrams of isoflavones were 
consumed daily.  A decrease in interleukin was also realized (20).   
 A 2011 study of healthy, obese, menopausal women published in Phytomedicine 
indicated that, after six months of treatment with a daily isoflavone extract consisting of 80 
mg of genistein, 16 mg of daidzein, and 3.2 mg of glycitein, a decline in both TNF-alpha and 
serum leptin was observed, along with an increase in adiponectin levels (31).   A different 
study suggested that a high soy protein breakfast was deemed more satiating than a normal 
soy protein breakfast, and people who ate 47 gr of soy protein daily lost weight as well as 
lowered their low-density lipoprotein (32). 
  
Cardiovascular Health 
 Lipid effect has not been well established for soy-based products (33), causing the 
FDA to reevaluate the cardiovascular health benefit statement for soy (34).  For example, one 
four-week study failed to show a significant effect in cholesterol levels when subjects 
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consumed three 16-ounce servings of vanilla soymilk daily (35), whereas another study 
found that after just three weeks there was a 20% increase in high-density lipoprotein (HDL) 
in subjects consuming soymilk (33); and four separate trials disclosed beneficial effects on 
arterial stiffness with the intake of soy and soy isoflavones (36).  
 In a longitudinal study published in 2008 in Diabetes Care, cardiovascular risks 
including LDL, total cholesterol, and serum triglyceride levels were significantly affected by 
soy consumption, and C-reactive protein levels decreased considerably (37). A second study 
reported in the Indian Journal of Clinical Biochemistry evaluated the cardiovascular effects 
of soy protein and isoflavone consumption in postmenopausal women.  The group 
consuming 30 gr/d of soy protein had a highly significant improvement in Apolipoprotein A1 
and B, as well as in their lipid profile, while women taking 60 milligrams of soy isoflavones 
daily exhibited significant improvement in triglyceride levels (38). 
  
Bone Mass Density 
 Bone mass density effect has also not been well established for soy.  While traditional 
soy foods significantly affect fracture protection and bone mineral density in Asians, using 
isolated soy protein in Western intervention studies produces inconsistent results.  Higher 
concentrations of isoflavones than are associated with the traditional Asian diet do not yield 
the same evidence as whole soy's positive effect on bones (39).  However, while there is 
increased urinary calcium excretion associated with animal protein, there is not with soy 
protein (40).   
 As published in the American Journal of Clinical Nutrition in 2010, the results of a 
three-year trial involving menopausal women demonstrated that soy isoflavones had only a 
modest effect on bones and just at the femoral neck (41).   A gender-specific study in 
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Singapore demonstrated a reduction in hip fracture risk between 21%-36% in women with 
dietary intakes of <49.4 gr/d of tofu, <2.7 gr of soy protein, and <5.8 mg of isoflavones, 
although this reduction did not occur in men (42) nor did it occur in two other studies 
involving Western men (43).  
 A two-year study involving healthy menopausal women evaluated soy 
supplementation through daily ingestion of supplements made from the stem of germinating 
soy seedlings (hypocotyl).  And although whole-body bone loss was reduced at a dose of 120 
mg/d, at common fracture sites there was no slowing of bone loss.  At the same time results 
indicated all blood chemistry remained within normal range, no differences were observed in 
endometrial thickness or uterine fibroids, and the supplement did not affect free thyroxine 
levels, as reported by the American Journal of Clinical Nutrition in 2009 (44).    
  
Thyroid Health 
 Genistein and daidzein have been identified as thyroid inhibitors (12).  A 
retrospective study concluded that teens fed soy formula as infants demonstrated twice the 
prevalence of autoimmune thyroid diseases of the control group or healthy siblings (45); 
however, soy products can produce insignificant effects on thyroid function in healthy adults 
(46).  A 2010 study demonstrated negligible affects on thyroid function when 
postmenopausal women consumed soy isoflavones for 3 years; yet an earlier 6-month study, 
also with postmenopausal women, indicated that half the subjects developed hypothyroid 
symptoms or goiter when consuming 30 gr of soybeans daily.  Interestingly, symptoms of 
hypothyroidism ceased after discontinuing soy for just one month (45).     
 Studies conducted decades ago revealed that infants consuming soy-based formula 
without iodine were capable of developing goiter and hypothyroidism.  It has been suggested 
	 12
since that time that those with autoimmune thyroid diseases, hypothyroidism, and iodine 
deficiencies should avoid soy (45).  Dr. Jorge Flechas, the foremost authority on iodine in the 
world, believes nearly 12% of the population to be iodine deficient and therefore 
recommends a simple 24-hour iodine load test to determine individual deficiencies (47).  A 
useful analysis, this test requires the ingestion of 50 mg of iodine and a complete collection 
of urine for 24 hours.  The idea behind this test is that when the body has attained maximal 
retention of iodine, urinary excretion increases.  The excretion is measured and calculated to 
represent the level of iodine available in the body.  Based on this calculation, the amount of 
iodine supplementation is determined for an individual.  Both medical professionals and 
laypersons have access to these tests for a reasonable fee (48).  
While the average American diet contains approximately 167 mcg of iodine daily, the 
Japanese diet contains significant levels of dietary iodine including 7,000 mcg daily from just 
kombu alone. The Japanese diet can vary from 5280 to 13,800 mcg of iodine daily and 
thereby exceed the upper safety limit of 1 mg by up to an average of 5-25 times.  However, 
these levels do not appear to negatively affect thyroid function in normal Japanese 
individuals.  Although studies show that an excessive intake of iodine can cause thyroid 
nodules, autoimmune thyroid disease, or hyperthyroidism, the Japanese instead demonstrate 
a protective affect towards both benign and malignant breast disease, and a lower incidence 
of cancers of the ovary, endometrium, and prostate (49).  In fact, iodine has been shown to 
effectively treat fibrocystic breast disease at doses of 3-6 mg daily (50).  Perhaps the reason 
for the positive effect soy demonstrates in protecting Asians from breast cancer is the fact 
that they have a diet higher in iodine, which offsets the goiterogenic effects of soy. 
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Soy proteins and isoflavones may affect serum T3 and/or T4 in humans and animals, 
and yet there remains inconsistent findings in studies (51). Consequently, soy is currently 
contraindicated for those with an iodine deficiency or thyroid disease (3).  For those on 
thyroid medication, it is recommended to consume soy at least two hours after taking the 
medication (3). 
  
Equol Producers 
 Recent studies indicate that bone resorption and metabolism may be dependent on the 
subject's capacity to produce equol in response to soy (3). Equol is produced by bacterial 
fermentation of the soy germ (1) and has a greater estrogen receptor-b affinity than diadzein.  
Equol-producing postmenopausal women showed significant lumbar spine bone mineral 
density and bone resorption with soy isoflavones (52).  People vary in how efficiently they 
can make the conversion of daidzein to equol depending on genetics and intestinal bacteria 
(13).  Findings reported in 2009 suggest 30%-50% of Westerners can produce the bacterially-
derived equol (8,53).  Some researchers believe that classifying the equol phenotyping of 
individuals may be the key as to whether soy protein diets are effective, but this remains yet 
to be established (3).   However, animal products, and especially milk products, have also 
been identified as dietary sources of equol, so urinary equol concentrations may not represent 
actual endogenous production from microbial metabolism in low soy-consuming populations 
(54).  Research published in Food Bioprocessing Technology still points to isoflavone 
activity in the body as being strongly influenced by bioavailability and absorption (55). 
  Fifty-four postmenopausal Japanese women were classified by equol-producing 
status.  After soy intervention there was no change in equol concentration in nonproducers 
(28).  However, in a study reported in 2010 in the Journal of Food Science, researchers 
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reported that equol excretion results indicated that younger subjects had higher equol-
producer ratios.  In addition, 20 non-equol-producing volunteers consumed 1000 mL of 
soymilk daily for 16 weeks and 8 of the 20 became equol producers (56). Thus, changing the 
diet may change the gut microflora and improve absorption (14).  Further, it was reported 
that 50% of women and 35.3% of men were equol producers (14,56).  In several studies, 
Asian men with low equol concentrations demonstrated prostate cancer; however, there 
appears to be no association realized in European studies (57). Synthetic equol used in 
experiments complicates research, as do cultural differences and lifetime exposure to soy (1).  
Early exposure to soy suggests an imprinting effect, which can delay tumor formation and 
increase chemoprotective properties (58).  
 
Early Life Intake 
 Early life soy intake is associated with less aggressive breast cancers (59), and 
evidence implies that the period of life when the breast is more susceptible to the effects of 
diet is childhood and adolescence (60).  Some studies demonstrate that the protective effects 
of soy are dependent upon consuming soy from early on and throughout one's lifetime, 
although the same protective effect does not hold true for isolated soy protein (21).  In a 
significant study involving more than 73,000 Shanghai women, a 2009 article in the 
American Journal of Clinical Nutrition reported that there was a considerable reduction in 
the risk of premenopausal breast cancer in women who consumed high amounts of soy 
during adolescence and adulthood (61).  Additional studies reveal that Asian breast cancer 
survivors who continue consuming soy at customary levels in their diet reveal better 
prognoses (21). 
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Soy-Based Infant Formula 
Reports indicate that between 20% and 36% of the infants in America are fed soy-
based infant formula (SBIF) (62).  Rarely do adults ingest more than 25% of their daily 
calories from soy protein, but infants fed SBIF get 100%.   According to Michael Shelby, 
director of the National Toxicology Program's Center for the Evaluation of Risks to Human 
Reproduction (CERHR), "free genistein is thought to have either low or no biological 
activity" (63).  The data from a pilot study in 2009 concur, reporting "whether the 
phytoestrogens in soy formula are biologically active in infants is still an open question" 
(62).  A study with adults revealed that after a high soy food meal, isoflavones could exceed 
postmenopausal estrogen levels by 103 fold (3).  However, the half-life of isoflavones is a 
short eight hours, and after 24 hours, levels return to baseline values (3,26).  
In May 2010, the National Toxicology Program released a draft on soy and its 
potential to cause adverse effects.  The expert panel concluded there is "minimal concern" for 
infants fed SBIF with regard to developmental effects (64).  The most cautious interpretation 
of the evidence in research thus far can suggest that parents should avoid feeding SBIF, 
whenever alternatives are possible, to neonatal male infants through the age of 5 months to 
avoid reducing testosterone levels during the period of the testosterone surge (65, 66).   
Current studies are underway through the United States Department of Agriculture at 
Arkansas Children's Nutrition Center (ACNC) in Little Rock (62).  The longitudinal, 
prospective controlled feeding study, "The Beginnings Study," began in September of 2002 
with 388 full-term healthy infants participating in a controlled feeding study.  The study has 
four groups of 95 infants each.  The first group was exclusively breast-fed; the second group 
consumed a cow milk-based formula (CMBF) with DHA; the third group consumed a SBIF 
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with DHA; and the last group was fed a SBIF without DHA.  While the ACNC's previous 
studies concluded no apparent long-term effects, whether positive or negative, in infants 
using SBIF versus CMBF, the current study will continue its investigation into brain 
development and functioning, sleep patterns, bone mineralization, metabolism and growth, 
body composition, and motor development.  These children will be followed through puberty 
and will be involved in multiple in-depth check-ups, which began with brief monitoring at 1 
month old.  Other brief check-ups occurred at 2, 4, and 5 months of age, while extensive 
testing (including tissue assessments and imaging) occurred at 3, 6, 9, and 12 months of age 
and then annually afterwards (67).   
Five years into the study, all children were within normal limits regarding growth and 
development (68), and SBIF-fed infants were indistinguishable from non-SBIF-fed infants.  
Translational research supports the view that early contact with SBIF and soy foods may 
actually offer health advantages such as improved bone composition and protection from 
breast cancer (64). 
 
Breast Cancer 
It is estimated that nearly 17,000,000 adults and children will be living with cancer in 
the United Stated by 2020.  In a six-year study of 1,954 patients evaluating the association 
between breast cancer survival and soy isoflavone intake, results indicated an inverse 
association.   Results of the Shanghai Breast Cancer Survival Study reported a significant 
decreased risk of death and breast cancer recurrence with soy food consumption (15,17,69).  
A study published in Breast Cancer Research Treatment also notes an inverse association, 
whether soy isoflavones or soy protein, regardless of tamoxifen treatment or estrogen-
receptor expression (70). A study among 358 Korean women, with a mean intake of 76.5 gr 
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of soy and 15 mg of isoflavones daily, also reflected no difference between estrogen or 
progesterone receptor status (71).  
Both tamoxifen and soy isoflavones bind to estrogen receptors, and some studies 
suggest soy consumption can improve survival to the degree tamoxifen has exhibited.  
Research suggests soy and tamoxifen as adjuvant therapies (72) while other studies find the 
same survival rate using soy regardless of whether tamoxifen was used as initial therapy for 
breast cancer (73).   Whether estrogen or progesterone receptor positive or negative, or in 
those taking tamoxifen as endocrine therapy, high isoflavones were associated with lower 
recurrence of breast cancer in postmenopausal women (67,74).   
More than 150 studies indicate that consuming <100 mg of soy isoflavones daily is 
unlikely to elicit adverse effects in breast cancer survivors or healthy individuals (12).  The 
large Shanghai Women's Health Study provided significant evidence of the protective effect 
of soy protein and soy isoflavones against premenopausal breast cancer (59).  In Asian 
women with a daily intake of approximately 5 gr of soy protein, a one-third reduction in the 
risk of pre and postmenopausal breast cancer was recognized (75). For every 10 mg increase 
in daily isoflavone intake, a 4% decrease in the risk of breast cancer was observed in Asian 
populations (70).  However, following migration and Westernization of diet, an increase in 
breast cancer incidence among Japanese women is being observed after successive 
generations (17). 
 
Prostate Cancer 
Men who consumed tofu and soy milk had a 26% reduction in the risk of prostate 
cancer (13); however, a one-year study involving 53 men on a daily high isoflavone 
supplementation of 450 mg of genistein and 300 mg of daidzein resulted in no change in risk 
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factor, equol levels, or PSA levels (76).  So although soy may block an enzyme allowing 
testosterone's conversion to estrogen, the reduction in prostate cancer risk may be associated 
with the type of soy consumed (2,77).  
A large, 20-year cohort study of 12,000 Seventh Day Adventist men in the United 
States found a 70% reduction in the risk of prostate cancer from consuming soy milk more 
than once per day.  Four other studies also demonstrate these results.  Low concentrations of 
genistein were found in Austrian men with prostate cancer, and there exist hypotheses stating 
low doses of soy found in Western diets might actually promote cancer (14). 
 
Soy in Cancer Treatments 
Genistein modulates cell survival pathways and sensitizes cancer cells to radiation 
and chemotherapy.  It may protect normal tissue from the damage of cancer treatments, due 
to its anti-inflammatory and antioxidant effects.  A small study involving children with 
cancer concluded that 8 mg of genistein daily, in conjunction with chemotherapy and/or 
radiation, resulted in less infection and bone marrow suppression as well as less abdominal 
pain and diarrhea.  Soy isoflavones prevented side effects from radiation in prostate cancer 
patients while enhancing the effectiveness of radiation therapy.  At a dosage of 200 mg/d, 
bowel, urinary, and adverse sexual symptoms induced by radiation were decreased as 
reported in Nutrition and Cancer last year (78). 
 
Guidelines for Future Research 
A host of factors may be the cause of varying outcomes in cancer studies, including 
an ability to form equol, to absorb soy, and ethnicity. The National Institutes of Health (NIH) 
have provided guidance for future clinical research on soy, such as determining lifetime 
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exposure, supplement use, and the equol-producing status of subjects. The NIH has 
determined that the quality of soy must also be addressed in research studies, as well as using 
the type and amount of soy Asians traditionally consume.  The NIH also suggests that soy 
products should be analyzed for bioactive constituents, growing conditions, harvesting, and 
storage conditions, part of plant used, and extraction and processing methods to ensure more 
accuracy and consistency in study outcome (79). 
 
Soybean Varieties and Isoflavone Profile 
 The distribution and retention of isoflavones are significantly affected in the 
processing of soybeans (18).  The isoflavone content of twenty varieties of soybeans from 
China, Russia, Serbia, and the United States was analyzed, with results showing the content 
as high as 4.59 gr and as low as 1.45 gr of dried weight (80).  When a variety of Brazilian 
soybeans were analyzed for isoflavone content, results ranged between 57–188 mg.  
Genistein varied from 39-57%, daidzein from 34-47%, and 8-17% for glycitein (81).  A 
variety of seeds from three Maryland locations examined for isoflavone content indicated a 
50% reduction in isoflavones in soybean lines grown for early maturing (82). 
 There are several industrial techniques used to process soy.  When soaking soybeans 
to manufacture soymilk, approximately 4-10% of the isoflavones are lost in the water (53). 
The isoflavone content of some processed soy has indicated a reduction of as much as 80%, 
which affects the estrogen content as well (3).  The temperature of the water and the grinding 
process can also have a negative impact on isoflavone retention.  In processing tofu, the 
coagulant can affect the isoflavone yield.  To remove compounds deemed undesirable in the 
final steps of processing soybeans, an acidified wash produces an additional loss of 22% of 
the isoflavone content (53). Interestingly, when patients at high risk for prostate cancer 
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consumed alcohol-washed soy protein, it reduced detection of markers for prostate cancer; 
however, nonwashed soy protein did not (5). 
 
Soy Manufacturing 
 The defatting process for soy is typically carried out with hexane.  Hexane, a 
chemical solvent and byproduct of gasoline refining, was introduced in the 1930s as an 
efficient and inexpensive technique to extract proteins from soy.  In this processing method, 
soybeans are bathed in hexane to separate the protein from the soybean oil (53).  In the final 
stages of soy processing, hexane is steamed out of the protein, but trace amounts of hexane 
are present in the food.  Residual concentrations of hexane are reported to be greatest for the 
6- to 8-year-old age group, with an estimated daily ingestion of 1.45 mg/kg of body weight.  
Extra virgin olive oil has reported residual concentrations as high as 19.1 to 95.3 mg/L (83).   
 The FDA does not set a limit for hexane residuals in food and does not require testing 
for residues by manufacturers.  However, hexane residual levels greater than 10 ppm are 
prohibited by the European Union.  The Cornucopia Institute in the United States found 
hexane residuals in soy foods with levels as high at 21 ppm (84) (see Appendix A).  
 Hexane is highly flammable and presents environmental risks. The Occupational 
Safety and Health Administration sets exposure limits to 500 ppm during an eight-hour shift. 
Employees working at soy processing facilities experience immediate skin irritation when 
exposed to hexane, developing blisters.  At 800 ppm for 15 minutes, employees develop 
upper respiratory and eye irritation, and narcosis at exposures of 1,000 ppm.  The Centers for 
Disease Control and Prevention have designated hexane as a neurotoxin.  Employees 
chronically exposed to hexane develop polyneuropathy, muscle weakness, and eye damage 
(84). 
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 The United States Environmental Protection Agency (EPA) tightly monitors and 
controls hexane, considering it a hazardous air pollutant, and heavy fines are imposed with its 
excessive release.  However, 19 million pounds of hexane were released into the atmosphere 
in 2009, with more than two-thirds coming from soy processing plants in the manufacture of 
health products, with petrochemical plants and tire factories making up the rest of the 
emissions (84).  Hexane can create ground-level ozone when reacting with other air 
pollutants, also posing health hazards (85).  While the EPA considers hexane hazardous, it is 
classified as non-carcinogenic based on the lack of data in humans, although when male rats 
were exposed to hexane, testicular damage was observed (86), and the incidence of liver and 
pituitary tumors increased in female mice.  Additionally noted was an increase in the number 
of bone marrow cell mutations in rats (87). 
 Research led by the Cornucopia Institute exposed the soy industry's hexane 
manufacturing process in 2009, and since that time many prominent natural foods companies 
have changed their extraction method to hydraulic expeller pressing.  This process extracts 
25-45% less soy protein and isolates than hexane, but companies such as Spectrum Naturals 
and Turtle Island Foods believe it is more environmentally responsible (84).  
 Hexane is not an ingredient or raw product; it is considered a processing aid and is 
therefore not listed on the food label.  Consumers must be aware that when contacting 
companies to inquire about hexane processing, they can receive misleading answers.  No 
ingredient can be derived from hexane, so careful interpretation should be used if the 
company states their soy is not hexane-derived – the real question is whether or not a hexane-
extraction process is used.  Some companies are not even aware their raw materials were 
exposed to hexane when purchasing soy from large suppliers.  Careful interpretation must be 
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exercised if the company informs consumers that they don't use hexane to process soybeans, 
because it doesn't occur in their own food processing plants (84).  
 
Genetically Modified Soybeans 
 Hexane processing is prohibited in foods labeled organic, as are pesticides and 
genetically engineered seeds.  Genetically modified (GMO) or genetically engineered (GE) 
plants have specific DNA alterations inserted into their genetic material to allow for 
herbicide tolerance, to increase insect resistance, or to produce one or more pesticides thus 
leading to advantages over crops grown conventionally.  In 2007, there were more than 353 
million acres in 23 countries growing GMO crops (88).  However, genetically modified crops 
are problematic in Japan and the European Union (EU) (89).  The EU has approved just two 
crops (potatoes and maize), so in 2009 when tests indicated trace amounts of unapproved 
genetically modified residues in soybeans imported from the United States, all shipments 
were halted.  Yet the Union's commissioner of agriculture broadcast this statement:  "If we 
make life too expensive for our farmers by having to source really expensive, completely 
GMO free imports, we put up the price and at the end of the day we end up putting our own 
farmers out of business and having to import meat from elsewhere.  In fact, from countries 
that use the very GMO that we're not allowed to use in Europe" (90).  
 In 1996 Roundup Ready soybeans initiated protests, concerns, and debates on the 
safety of genetically modified crops (91), as there were no long-term studies conducted to 
indicate the effects genetic modification of plants may have on animals, plants, humans, and 
the environment (92).  Both animals and humans consume genetically modified crops, the 
main of which is soybeans, accounting for 57% of the global biotech area in 2006.  Research 
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has shown that mice fed genetically modified soybeans since gestation acquired harmful 
pancreatic functioning changes at both the microscopic and ultramicroscopic levels (93). 
 In truth, most studies conducted with GMO plants demonstrate toxic effects on the 
liver, pancreas, kidneys, and reproductive organs.  Anti-GMO groups argue that genetically 
modified foods should be thoroughly tested in long-term clinical studies to determine the 
effect on human health, also noting that GMO foods increase anti-nutrients, pose problems 
for allergic responses, and could transfer antibiotic-resistant genes to bacteria in the 
gastrointestinal tract. Studies reveal these viral DNA fragments have been detected in the 
milk from cows and in the tissues of mice and chicken fed GMO crops (94). 
 In a study conducted in 2008, Roundup Ready soybeans caused inflammation in the 
intestinal cells of salmon, leading researchers to question whether long-term use of 
genetically modified crops may lead to chronic inflammation of the gastrointestinal tract and 
ultimately lead to cancer.  Exposing infants and children to GMO foods also raises concern.  
When pregnant mice were fed genetically modified foods, DNA fragments were detectible in 
both fetuses and newborns, indicating a transfer through the placenta.  A study in Russia 
resulted in 56% of rats dying when fed GMO soy, and also suggested that maternal ingestion 
could be a mutagenic factor for developing fetuses (94).  Other recent studies indicate that 
Roundup Ready soybeans interfere with estrogen production, depress respiratory activity, 
alter the inner membrane of the mitochondria, and point to an increase in the physiological 
aging process (95).  
 Additionally, there is concern about the ability of genetically modified foods to either 
change the level of expression in genes by turning on those previously not being expressed, 
or perhaps even silencing certain genes.  This emphasizes the fact that the duration of 
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exposure in studies must be increased and genetically modified foods more thoroughly 
studied in order to determine toxicity and reach sound conclusions as to the safety of GMO 
foods (94). While there appear to be no adverse effects in short-term studies, 
multigenerational studies have not yet been conducted, although one long-term study 
indicated a reduction of 10% in the animal's life span (88).   
 When limiting studies to a single generation, reproductive capacity is not assessable. 
Concerns surround normal ovulation, fertilization, and implantation for females, and 
testicular health and accessory organ functioning in males.  Multigenerational issues for both 
sexes include developmental effects in utero, postnatally, puberty, and lifetime reproductive 
health, all of which have not been studied (88).   
 Regulatory tests are not mandatory nor conducted independently, and results are kept 
secret by manufacturers of genetically modified crops.  In fact, some manufacturers' studies 
concluded that no further testing was necessary even after noting the possibility of 
hepatorenal toxicities.  In 2010, the International Journal of Biological Sciences published an 
article revealing that the authors had obtained the previously hidden raw data from 
Monsanto, through lawyers and a court order. In reviewing three toxicological tests that 
Monsanto conducted, several shortcomings of the studies' designs were noted, specifically: 
too small a number of animals were included in the study; only 10% of the animals were 
analyzed biochemically; and each test was performed only once on rats fed for a mere 3 
months' time, all suggesting controversial protocols with Monsanto and the international 
committees who did not reject the results of such experiments (96).   
 Moreover, the papers obtained by court order indicate Monsanto's studies revealed an 
increase in the heart size in male rats of 11% as well as signs of "chronic progressive 
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nephropathy," while females demonstrated an increase in plasmatic triglycerides.  Monsanto 
had previously sought to prevent routine independent and reproducible studies by attempting 
to block confidential access to the raw data, until losing their case in the Court of Appeals in 
Germany.  The authors noted that studies funded by industry do not suggest the possible side 
effects of genetically modified foods, and liken industry-funded soy studies to the 
controversy surrounding bisphenol A where no adverse effects were cited in industry-funded 
studies and yet hazards were highlighted in 90% of government-funded studies (96). 
 
Consumers' Image of Soy 
 Soy food consumption is highest among Asian Americans, Seventh Day Adventists, 
and vegetarians.  Those who do not consume soy perceive soy food as something for people 
with allergies and for Asians, vegetarians, and hippies (97).  According to the United 
Soybean Board, 8 in 10 consumers in 2010 consistently rated soy foods as healthy for the 
heart, understood soy to reduce the risk of certain cancers, and believed that it was helpful for 
weight management.  The United Soybean Board also reports that consumers gather 
information on health from television news (47%), the Internet (44%), magazines (37%), 
word of mouth (35%), and the newspaper (31%).  Only 17% of consumers obtain 
information from a health professional (98). 
 
Credibility of Soy Information 
For the past several years, some lay media have been successful in delivering a 
message on the dangers of soy consumption.  One of the more prominent groups is the 
Weston A. Price Foundation (WAPF). Weston Price passed away in 1948 and although his 
training was in dentistry, he was fascinated with nutrition. This group, headed by Sally 
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Fallon (a self-proclaimed health activist with no nutritional training), Mary Enig, PhD (a 
licensed nutritionist), and James Mercola, D.O., claim SBIF inhibits the absorption of 
nutrients needed by infants and “contains the equivalent of at least five birth control pills per 
day” (99). Along with strong anti-soy and anti-vegetarian sentiments, the group promotes 
"Nourishing Traditions," which strongly advocates a diet high in butter, cream, milk, meat, 
and eggs and vehemently opposes low-fat diets, high-fructose corn syrup, and the idea that 
elevated blood serum cholesterol is dangerous (100). 
In the past (up to the year 2006), the Foundation suggested that when children are fed 
soy they experience “extreme emotional behavior, learning disabilities, depressed thyroid, 
pituitary insufficiency, irritable bowel syndrome, asthma and immune problems.”  Most 
disturbing is their message that feeding male infants SBIF can alter their future sexual 
orientation and their related suggestion that mothers who can't breastfeed prepare homemade 
formula based on whole milk, or give infants a homemade formula made from liver (100).  
Most of these statements have been removed from the Foundation's website, but other non-
credible information remains. 
In reviewing "Soy Alert!" on the WAPF website, 67 articles were featured by various 
authors on the dangers of soy.  Oddly, most of these authors have no formal training, and 
they referenced articles that bear no meaning in supporting what they are reporting in their 
writing.  For instance, Linda Joyce Forristal has CCP and MTA as her credentials; however, 
these credentials stand for Certified Culinary Professional and Master's in Tourism 
Administration.  Another author, Maria Van Heemstra, trains people in the construction 
industry and promotes solar cooking, while Andreas Schuld belongs to Parents of Fluoride 
Poisoned Children.  Not to imply that these individuals cannot do research to back up their 
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articles, but out of the 67 articles only approximately 20% included references, and none of 
those references were to recently published studies or research conducted in the past ten 
years (100). 
In order to access Dr. James Mercola's website, one must subscribe. Articles and 
videos indicate the number of times they have been viewed; for instance, the anti-soy video 
"This 'Miracle Health Food' Has Been Linked to Brain Damage and Breast Cancer" has been 
viewed 496,209 times, while the article "The Evidence Against Soy" has been viewed 
197,932 times as of November 2011.  Dr. Mercola maintains the only safe way to consume 
soy is in its fermented form, such as in natto, tempeh, miso, and soy sauce. Interestingly, out 
of 72 "endnotes," his work referenced studies mostly conducted in the 1970s and dated as far 
back as 1925.  There are very few references cited for studies conducted on soy over the past 
decade (101). 
A third soy adversary is New York Times bestselling author Ann Louise Gittleman.  
Ms. Gittleman refers to herself as a "Dr. Ann Louise, First Lady of Nutrition" after obtaining 
a degree in nutrition upon completing a non-accredited, distance-learning course in 2002 
from the now-defunct Clayton College once based in Birmingham, Alabama.  On Ms. 
Gittleman's website one article suggests, "Manufactured soy is linked to decreased fertility 
and possible thyroid problems." She cites nine sources to support her claim.  Two of the 
sources reference her own books, and two of the remaining seven are duplicate articles.  
Upon reviewing the remaining five sources, an interesting discrepancy was discovered (102).   
Ms. Gittleman's first article from PubMed merely suggests soy does not improve lipid 
profiles in postmenopausal women and has nothing to do with fertility or thyroid issues.  The 
second article simply lists soy as one of the ten most frequent foods with the potential of 
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triggering allergic responses, again never mentioning thyroid or fertility issues.  A third 
article compares dairy with soy and reports that "soy exerted no significant effect."  In like 
fashion, the three remaining referenced works bear no relevance to support her article. It's 
painfully apparent there is an incredibly strong need to educate the public on how to obtain 
accurate health information on soy (102). 
 
Health Professionals and Soy Recommendations 
 With more than 2,000 peer-reviewed articles relating to soy published each year, 
health professionals have volumes of credible information for continuous updates on soy.  
The United Soybean Board reports that 80% of dietitians view soy favorably (98), but what 
about the other 20%?  The controversy over soy and breast cancer leaves some health 
practitioners uneasy.  On the one hand, clinicians are advised to suggest that soy food 
consumption by breast cancer patients is probably safe and may even offer long-term 
protection from recurrence (15).  Other studies suggest soy can stimulate cancer cells and 
should be avoided (2).  The American Cancer Society recommends breast cancer survivors 
avoid high intakes of soy (13).  Nurses are advised to include soy in dietary assessments and 
to become more knowledgeable regarding soy and its components (103).   
 When advising patients, clinicians should be aware of both the quality and quantity of 
soy consumed (15) although this can be problematic when the content of isolates is not 
labeled on soy foods.  Iowa State University has created the first isoflavone database of foods 
analyzed for their content of genistein, diadzein, and glycitein.   The database includes a 
Confidence Code to indicate the quality of the data.  The entire document is attached to this 
thesis as Appendix B, Documentation for the USDA-Iowa State University Isoflavones 
Database. 
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 This thesis examines consumer awareness of soy along with where consumers 
obtained the information enabling them to form their opinion on the health implications of 
soy.  Therefore, the following research questions are proposed: 
 
RQ1: What is the current understanding of the public regarding health implications 
and the ingestion of soy for certain health conditions? 
 
RQ2: Where have consumers obtained information regarding the health implications 
of soy that contributed to their opinions and beliefs?  
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Chapter 3: Research Methodology 
 
 
Materials and Methods 
 A convenience sample of consumers was selected to provide information in regard to 
their perceptions regarding soy's health implications.  Participants were asked to complete a 
survey with five questions assessing their awareness of the health implications of soy.  The 
questions were developed following a review of current literature.  The first question listed 
12 health issues and asked respondents to rate whether they believed soy was "beneficial," 
"detrimental," or had "no effect," for each of the conditions listed.  If a respondent did not 
have an opinion or was uncertain, his or her response was indicated as "not sure." 
 The second question asked subjects where they obtained their information on soy's 
health implications.  The third question inquired as to whether participants felt there were 
certain conditions where soy would be contraindicated. The fourth question inquired as to 
whether the respondent consumed soy and, if so, in what form.  The fifth question assessed 
the subject's knowledge of the manufacturing process for non-organic soy product. 
 Two additional questions sought information on the participant's demographics, and 
any qualitative comments participants felt the desire to share regarding soy, in order to more 
fully explore specific consumer opinions.  A copy of the survey is available as Appendix C.  
By the third group of consumers, no new information was obtained, indicating that an 
adequate sample had been realized and that the study had reached its point of saturation. 
 
 
Study Population 
 Participants were individuals interested in learning more about holistic health and 
complementary medicine.  A small number (25%) of health professionals were in attendance 
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at the seminars; however, for the vast majority this was the first class they had ever attended 
on health.  Prior to starting each seminar, Power Point slides were shown to describe this 
study, and participants were asked to voluntarily complete a survey questionnaire regarding 
soy, as approved by Eastern Michigan University's Human Subjects Review Committee 
(Appendix D). 
 Between August 26 and November 4, 2011, a convenience sample of 242 individuals 
in six states consented to participate and complete the questionnaire: 
   Atlanta, GA – August 27 
   San Diego, CA - September 9 
      Birmingham, AL - September 17 
        Altoona, PA - October 8 
        Ann Arbor, MI - October 22 
   Buffalo, NY – November 5 
      There were significantly fewer males (15%) than females (85%).  The majority of the 
population was Caucasian (82%), followed by African Americans (12%) and other race 
(6%). The mean age was 52.42 (range: 18-92 y). Initially, there was some concern that 
individuals participating in the study would be more health conscious than average and 
would skew the data.  However, only 25% of participants were employed in the health field.  
Of the remaining, 31% of study participants were professionals or worked in an office, 17% 
were retired, 12% were employed in sales, 11% were homemakers, 7% were in academia, 
7% held jobs as laborers, 5% were business owners, and 9% had various other professions. 
 Surveys automatically protected each participant's confidentiality as no name was 
entered, nor other data considered private regarding the participant's location, health status, 
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financial information, or educational background.  Upon completion of the questionnaire, 
participants in the survey were compensated with a sample of the herbal remedy, "Solstic 
Immune." 
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Chapter 4:  Results and Discussion 
 
Analysis and Discussion of Findings 
 The aim of the present study was to determine consumers' opinions and perceptions 
of soy in reference to its perceived health implications.  Further, the study sought to compare 
attitudes regarding soy by identifying where consumers acquired the information from which 
they formed their beliefs. A structured questionnaire was administered to a convenience 
sample in order to collect information from participants regarding their awareness of the 
health implications of soy.  Demographic and lifestyle characteristics solicited included race, 
age, occupation, whether they were cancer survivors, and whether they consumed soy and, if 
so, in which form.  Additional information was collected as to where they obtained their 
impressions of soy's safety.  Last, participants were invited to share any qualitative comments 
regarding the consumption of soy.   
 Findings regarding views of soy as beneficial and detrimental are presented, as well 
as the uncertainty expressed from the majority of respondents. This chapter will also discuss 
findings by subgroups, namely differences in opinions between men and women; those who 
are in the health profession and those who aren't; those who are cancer survivors and those 
who have not had cancer; advocates and non-advocates of the Weston Price/James Mercola 
message; consumers and non-consumers of soy; and those who have researched soy further 
and those who have not done so. The results clearly demonstrate a strong need for consumers 
across the nation to have access to accurate and up-to-date health education in regard to soy.   
  
RQ1: What is the current understanding of the public regarding health implications 
and the ingestion of soy for certain health conditions? 
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food with less land and water to feed a hungry world in an environmentally sustainable way" 
(106).  
 However, while none of the additional qualitative statements that participants offered 
on surveys mentioned the environmentally hazardous soy hexane manufacturing process, out 
of the additional statements received, 21% cited the dangers of GMO soy as most 
problematic: 
• "I think GMO soy is causing most of the detrimental health conditions." 
• "I'm still unclear about soy.  Hear most soybeans are GMO so limit my intake." 
• "Opposed to soy due to GMOs." 
• "20 years ago soy was good.  Stay away from GMO." 
• "No GMO for sure." 
• "Monsanto and GMO are problematic in my mind." 
• "Very concerned about GMO.  I feel this is causing the soy problems." 
There remains a tremendous amount of doubt concerning the health implications of 
soy as shown in Figure 9, and oddly the uncertainty regarding soy's health effect on 
cardiovascular health remains the highest. Weston A. Price Foundation members petitioned 
the FDA to retract the "soy-prevents-heart disease claim." In 2009 Foundation officers 
delivered a 65-page petition to FDA offices and asked for a public hearing on issues raised in 
the petition (107).  The Foundation's website can be quite convincing to those not 
understanding how to determine the credibility of health information. 
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Figure 9. Total "Uncertain" Responses to Soy's Effect on Health 
 
Qualitative statements gathered from survey data reflect participants' uncertainty with 
soy: 
• "Very confused about all the info on soy."  
• "I have mixed feelings." 
• "It seems there is a lot of conflicting information regarding soy." 
• "There is a lot of confusion over soy.  I hear good and bad." 
• "So much information going both ways, I don't know what to believe." 
 
RQ2: Where have consumers obtained information regarding the health implications 
of soy that contributed to their opinions and beliefs?  
 
 A 2004 study found the Internet to be the most frequent source for seeking health 
information, followed by television, magazines, and family and friends (108).  While the 
United Soybean Board reported the same sequence of health information-seeking behaviors 
in 2011 (106), results of this study indicate magazines represent the main source of 
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 Unfortunately, not all health information is credible.  Websites can be authored and 
published by anyone without expert/peer review or editorial processes, and thus consumers 
are relying on the site's credibility based on brand, visual design, and site traffic.  With 80% 
of the adult population seeking health-related information on the Internet annually, the 
possibility of acquiring misinformation is paramount (109). 
 This study may have discovered a possible discrepancy in previous soy reporting by 
identifying a group of extreme anti-soy members and their associated pattern of 
nonconsumption of soy due to their awareness of GMO soy and detrimental soy 
manufacturing practices and their strong adherence to the (albeit biased) messages of the 
Weston A. Price Foundation and Dr. James Mercola.    
 The author questions whether the perceived danger of soy is more likely due to the 
soybean's unfortunate close affiliation with both GMO and hexane.  This affiliation gives the 
illusion that the bean itself is dangerous for consumption when, in fact, the DNA fragments 
from GMO soy and the carcinogenic factors associated with hexane may be the reason for 
soy's sometimes detrimental effect on the body – an effect that would not be the case in an 
organic, non-GMO, unprocessed soybean.  
 The author suggests that perhaps the National Institutes of Health guidelines for 
future clinical research on soy (79) should include the variables hexane processed and GMO 
soybeans in order to obtain clearer scientific evidence to help support or dispel health claims 
made to consumers and lessen their uncertainty about soy.  If the results conclude that all 
variables have been accounted for and soy is positively associated with health gain, 
consumers will feel less angst about increasing regular soy consumption.   
	 46
  The insight gained from the findings in this study provide valuable information 
regarding consumers' opinions on the health implications of soy, where they obtain their 
health information, and their resulting soy consumption patterns, as well as identifying anti-
soy groups. 
	 47
Chapter 5:  Conclusion and Recommendations 
 
Summary of Findings  
 To the author's knowledge, this is the first study to evaluate the relationship between 
an awareness of soy's health implications and where the study population obtained 
information that helped form their perceptions. The major findings in this study were the 
sizeable amount of uncertainty consumers have regarding soy as well as the identification of 
strong consumer attitudes and beliefs emanating from anti-soy members.  
 Misinformation and uncertainty leave consumers asking for clarification.  Of the 
individuals sharing any closing thoughts on soy, 27% claimed they had little knowledge 
regarding soy, admitted that they were confused by all the conflicting information, or 
expressed a desire to learn more. 
• "My knowledge is very limited. Want to hear more about soy."   
• "Don't know much at all, other than hearing it was a better alternative to processed 
milk." 
• "Totally ignorant of the facts.  How often should you consume soy per week?" 
• "Really don't know a lot about soy. Tasted soy milk but really didn't like it." 
• "I would like to know more about it." 
• "Not completely sure of all the facts to make a final decision, need to read more 
research." 
 
Conclusion and Practical Implications 
Soy has been a key plant source of protein for Asians for thousands of years, and 
many studies suggest soy to be a protective factor for humans by reducing the risk of a 
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variety of cancers including colorectal, gynecological, and breast (6).   It has also been 
suggested that when children and adolescents are exposed to isoflavones, with as little as one 
serving of soy daily, the risk factors for cancer are reduced by as much as 50% (60), and 
existing data suggest that normal dietary levels of isoflavones do not adversely impact either 
the progression or the risk of estrogen-dependent cancers (3).  
However, some Westerners exceed 100 mg/d of soy isoflavones, an amount that <5% 
of Asians consume.  In addition Asians typically eat soy that is minimally processed, while 
Westerners consume processed soy foods in the form of vegetarian meat alternatives, soy 
protein powders, and capsules, which results in isoflavone amounts above and beyond those 
consumed in Asian countries.  Studies have found when mice were exposed to processed soy 
foods, tumor growth increased in comparison to mice consuming soy that was less processed, 
raising the question of whether those with cancer should be concerned with processed soy 
(110). 
The United States Department of Agriculture (USDA) is now recommending soy 
foods.  Just last year the USDA released their dietary guidelines to include soy as an 
alternative source to lean protein (111). In response to one of the WAPF claims that Asians 
eat very little soy, Taiwanese author Jean Tsai writes, "Have any of these people lived in an 
Asian home?  Do they know any Asians?  I happen to know a lot of Asians that I'm related to 
and soy products are pounded on a regular basis. No one I know has a tiny 7 grams a sitting.  
This is bogus."  Her humor continues when addressing the anti-soy contingents who suggest 
phytoestrogens feminize boys and lower their sperm count; "Last time I checked, Asia was 
being accused of overpopulation.  There doesn't seem to be any low sperm count there.  And 
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if soy was super-feminizing, you would think the average Asian woman would have the 
figure of Pamela Anderson" (112). 
Dr. Andrew Weil concurs with Ms. Tsai's pro-soy stand and is also aware of the 
"internet paranoia on the subject of soy."  Dr. Weil adds that Japanese women consume a lot 
of soy and yet have 1/5 the rate of breast cancer of Western women.  He suggests that soy 
can interfere with thyroid functioning but "only if you have a thyroid disorder to begin with" 
or do not have enough iodine in the diet (113).  Consumers need to have accurate information 
on soy, as do health educators and other health professionals.   
In summary of the research outcomes as they stand today, it is suggested that people 
limit soy if they have either an iodine deficiency or a diagnosed thyroid disorder, if they are 
allergic to it, or just don't care for it.  Further recommendations are to go light on processed 
soy but enjoy it in its fermented form, and buy organic and non-genetically modified soy 
when available.  It is advised to use caution when taking soy isoflavone supplements until 
further research has been completed and, last, avoid Dr. James Mercola and the Weston A. 
Price Foundation's soy fear-mongering.   
 
Limitations 
This study was an attempt to describe consumer beliefs and awareness of soy.  
Despite the strength of this study, limitations exist. Due to recruitment in a health education 
setting, a knowledge bias may exist, as attendees may have an interest in complementary 
therapies and have a greater knowledge of soy than the broader population. Initially, there 
was some concern that individuals participating in the study would be more health conscious 
than average and would skew the data.  However, only 25% of participants were employed in 
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the health field.  Last, given the small sample size and the fundamental limits of surveys, 
caution should be exercised when generalizing and interpreting the results.   
However, in spite of the limitations, the findings suggest practical applications and 
provide new research questions such as whether the soy used in experimental designs is 
GMO/non-GMO or hexane processed.  In addition, when surveying consumers on their 
beliefs regarding soy, defining where consumers get their health information may make for 
more sound data analysis.  Finally, with the amount of uncertainty represented in the survey 
results on the part of consumers, it is of great necessity that health professionals and health 
educators are educated on soy and are cognizant as to the credibility of the information they 
share with consumers. 
 
Recommendations for Future Research 
With the lack of consistency in studies examining soy, future studies are needed to 
determine what is safe to consume and in which amounts.  Ideally, future studies should 
evaluate the added variables of GMO/non-GMO and hexane-processed soy to extend current 
findings when including information on the source, processing, environmental conditions, 
seed source, and nutritional composition of the soybeans used.  It may also be beneficial to 
determine iodine status in test subjects.  These studies are warranted to confirm the 
association of soy consumption with health implications.  Future surveys and research 
regarding soy consumption should also be extended to include nutrition educators and health 
professionals in order to determine the accuracy of their knowledge on the subject, due to 
their interactions with consumers. 
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Summary 
With soy consumption increasing worldwide, research has exploded, suggesting soy's 
ability to reduce the risk of disease. Soy is not a hormone or a carcinogen.  It has just been 
misrepresented. It isn't a miracle food nor is it a dangerous food. When properly grown, 
manufactured, prepared, and consumed in acceptable amounts, soy can be a useful protein 
source to include in a healthy diet with 25 gr/d of whole soy food protein considered 
beneficial to health, and the avoidance of isolated soybean components.   
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Appendix A Cornucopia Guide to Hexane-Extracted Soy Foods 
Guide to hexane-extracted soy in nutrition bars. 
http://cornucopia.org/hexane-guides/hexane_guide_bars.htmlhttp://cornucopia.org/hexane-
guides/hexane_guide_bars.html25  
 
Brand 
Name Product  Ownership 
Organic 
Status 
Free of Hexane-
Extracted Soy 
Protein? 
 
Alpsnack All bars Independent Company  
Amazing 
Grass 
Green Superfood 
Bars Independent Company  
Bear Fruit All bars 
Independent Company 
(Mountain Organic 
Foods) 
 
Bumble Bar All bars Independent Company  
Clif "C" 
Bar "C" Bars 
Independent Company 
(Clif Bar) 
70% Organic 
Ingredients 
 
Caution: Other Clif 
products, including 
Clif Bars, contain 
non-organic soy 
protein ingredients, 
likely hexane-
extracted 
Clif Nectar Nectar Bars Independent Company (Clif Bar) 
  
Caution: Other Clif 
products, including 
Clif Bars, contain 
non-organic soy 
protein ingredients, 
likely hexane-
extracted 
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Garden of 
Life Living Foods bars Independent Company  
Genisoy Organic Bars Independent Company
  
Caution: Other 
Genisoy products 
contain non-organic 
soy protein 
ingredients, likely 
hexane-extracted 
Hammer All bars Independent Company  
Honey 
Stinger Protein Bars Independent Company Not organic 
 
Caution: Other Honey 
Stinger products 
contain non-organic 
soy protein 
ingredients, likely 
hexane-extracted 
Kind Plus Antioxidants bars Independent Company Not organic 
 
Caution: Other Kind 
Plus products contain 
nonorganic soy 
protein ingredients, 
likely hexane-
extracted 
Larabar All bars Public Corporation (General Mills) Not organic  
NuGo Organic Bars Independent Company
  
Caution: Other NuGo 
products contain 
nonorganic soy 
protein ingredients, 
likely hexane-
extracted 
Nutiva All bars Independent Company  
Odwalla 
Original Bars, 
Superfood Bars, 
Chewy Nut Bars 
Public 
Corporation(Coca-
Cola) 
Not organic 
 
Caution: Odwalla's 
Protein Bar contains 
nonorganic soy 
protein isolate, likely 
hexane-extracted. 
Most Odwalla contain 
hexane-extracted soy 
lecithin, a minor 
ingredient 
Nature's 
Path Optimum Bars Independent Company  
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Organic 
Food Bar All bars Independent Company  
Potent 
Foods 
Maca Bars and 
Potent Life bars Independent Company  
Pure Pure Bars Independent Company  
Raw 
Revolution All Bars Independent Company  
SoyJoy All bars Independent Company (Pharmavite) Not organic  
Vega Vega Whole Food Bars 
Independent Company 
(Sequel Naturals) Not organic  
Wild Bar All bars Independent Company  
Zen 
Organic 
Foods 
All bars Independent Company  
Balance 
Bar 
Original, Bare, 
Gold and Carbwell 
Bars 
Private Equity Firm 
(Brynwood Partners) Not organic 
 
 
Can Do Kid All bars Independent Company Not organic 
 
 
Clif Bar All Clif bars Independent Company (Clif Bar) 
70% Organic 
Ingredients 
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Clif 
Builder's 
Bar 
All Builder's bars Independent Company (Clif Bar) Not organic 
 
 
Clif Mojo 
Bar All Mojo bars 
Independent Company 
(Clif Bar) 
70% Organic 
Ingredients 
 
 
Genisoy 
Non-Organic Bars, 
including Ultra 
and Protein 
Crunch bars 
Independent Company Not organic 
 
 
Greens Plus Energy bars 
Independent Company 
(Orange Peel 
International) 
Not organic 
 
 
Honey 
Stinger Energy bars Independent Company Not organic 
 
 
Kind Plus Protein bars 
Independent Company 
(Peaceworks 
Holdings) 
Not organic 
 
 
Luna Bar All Bars Independent Company (Clif Bar) 
70% Organic 
Ingredients 
 
 
Luna 
Protein Bar All Bars 
Independent Company 
(Clif Bar) Not organic 
 
 
NuGo Non-organic bars Independent Company Not organic 
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Odwalla Protein Bars Public Corporation (Coca-Cola) Not organic 
 
 
Power Bar Harvest and Nut Naturals Bars 
Public Corporation 
(Nestle) Not organic 
 
 
Pria Bar All bars Public Corporation (Nestle) Not organic 
 
 
Promax Promax and Promax 70 Bars 
Private Equity Firm 
(Marwit Capital) Not organic 
 
 
Pure 
Protein All bars Independent Company Not organic 
 
 
Think Think Thin Protein and Crunch bars Independent Company Not organic 
 
 
Whole 
Foods 365 Super Greens Bar 
Public Corporation 
(Whole Foods Market) Not organic 
 
 
Zone 
Perfect 
Zone Perfect and 
Fruitified Bars 
Public Corporation 
(Abbott Nutrition) Not organic 
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Guide to hexane-extracted soy in meat alternatives. 
http://cornucopia.org/hexane-guides/hexane_guide_meat_alternatives.htmlhttp://cornucopia.org/hexane-
guides/hexane_guide_meat_alternatives.html56  
 
Brand Name Product Ownership Organic Status 
Free of 
Hexane-
Extracted Soy 
Protein? 
 
Amy's 
Kitchen All Products 
Independent 
Company 
70% 
Organic 
Ingredients
 
 
Asherah's 
Gourmet All Products 
Independent 
Company 
 
 
Boca "Made With Organic Soy" patties, burgers and links 
Public 
Corporation 
(Kraft - 
Philip 
Morris) 
70% 
Organic 
Ingredients
 
Caution: Other 
Boca products 
contain 
nonorganic soy 
protein 
ingredients, 
likely hexane-
extracted 
Field Roast 
Grain Meat All Products 
Independent 
Company 
Not 
Organic 
 
 
Gardenburger 
"Garden 
Vegan,""Gourmet,""Original"
and "Sun Dried Tomato Basil"
Public 
Corporation 
(Kellogg's) 
Not 
Organic 
 
Caution: Other 
Gardenburger 
products contain 
non-organic soy 
protein, likely 
hexane-
extracted 
Helen's 
Kitchen All Products 
Independent 
Company 
 
 
Morningstar 
Farms 
"Made With Organic Soy" 
burgers and patties 
Public 
Corporation 
(Kellogg's) 
70% 
Organic 
Ingredients
 
Caution: Other 
Morningstar 
products contain 
non-organic soy 
protein 
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ingredients, 
likely hexane-
extracted 
Primm Spring 
Foods All Products 
Independent 
Company 
Not 
Organic 
 
 
Soy Deli Tofu Burger 
Independent 
Company 
(Quonghop) 
Not 
Organic 
 
 
Tofu Shop All Veggie Burgers Independent Company 
 
 
Tofurky All Products 
Independent 
Company 
(Turtle Island 
Foods) 
Not 
Organic 
 
 
Trader Joe's Veg Masala Burger Independent Company 
Not 
Organic 
 
Caution: Other 
Trader Joe's 
products contain 
non-organic soy 
protein 
ingredients, 
likely hexane-
extracted 
Trader Joe's Organic Tofu Burger Independent Company 
 
Caution: Other 
Trader Joe's 
products contain 
non-organic soy 
protein 
ingredients, 
likely hexane-
extracted 
Wildwood All Products Independent Company 
 
 
Boca Chick'n, Burgers and Sausages
Public 
Corporation 
(Kraft - 
Philip 
Morris) 
Not 
Organic  
Dr. Praeger's Veggie Burgers, Veggieballs and Veggiepockets 
Independent 
Company 
Not 
Organic  
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Fantastic 
World Foods 
Vegetarian Sloppy Joe, 
Vegetarian Chili, Taco Filling 
Mix 
Public 
Corporation 
(United 
Natural 
Foods) 
Not 
Organic  
Franklin 
Farms 
Veggidogs, Veggiballs, 
Veggiburgers and Chick'n 
Nuggets 
Independent 
Company 
Not 
Organic  
Gardein Vegetarian entrees Independent Company 
Not 
Organic  
Gardenburger 
Burgers (Black Bean Chipotle, 
California Burger, Classic, 
Flame Grilled, Portabello and 
Veggie Medley), Breakfast 
Sausage and Herb Crusted 
Cutlet 
Public 
Corporation 
(Kellogg's) 
Not 
Organic  
Health is 
Wealth Vegan meat alternatives 
Independent 
Company 
Not 
Organic  
Lightlife 
Tofu Pups, "Smart" Meat 
Alternatives, Gimme Lean and 
Burgers 
Public 
Corporation 
(ConAgra) 
Not 
Organic  
Morningstar 
Farms 
Veggie Patties, Burgers, 
Chick'n, Buffalo Wings, Meal 
Startes, Veggie Bites, Veggie 
Cakes, Dogs 
Public 
Corporation 
(Kellogg's) 
Not 
Organic  
Soy Boy 
Okara Courage Burgers, Tofu 
Breakfast Links, Not Dogs and 
Vegetarian Franks 
Independent 
Company 
(Northern 
Soy) 
Not 
Organic  
Spice of Life Meatless Meats Independent Company 
Not 
Organic  
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StarLite 
Cuisine Soy Tacos and Soy Taquitos 
Independent 
Company 
Not 
Organic  
Trader Joe's Chicken-Less and Beef-Less Independent Company 
Not 
Organic  
Vegetarian 
Plus 
Vegetarian Chicken, 
Vegetarian Fish Fillets, 
Vegetarian Black Pepper 
Steaks, Vegetarian Lamb 
Independent 
Company 
(VegeUSA) 
Not 
Organic  
Veggie Patch 
Veggie Dogs, Veggie Sausage, 
Veggie Meatballs and Meatless 
Burgers 
Independent 
Company 
(Food Tech 
International)
Not 
Organic  
Whole Foods 
(Whole 
Kitchen) 
Meatless Breakfast Sausage, 
deli bar's meat alternatives 
Public 
Corporation 
(Whole Foods 
Market) 
Not 
Organic  
Yves Veggie 
Cuisine 
Burgers, Meat Alternatives, 
Entrees 
Public 
Corporation 
(The Hain 
Celestial 
Group) 
Not 
Organic  
The guides are based primarily on information acquired through exchanges with industry participants. 
Cornucopia staff members contacted companies that produce and market meat alternatives and nutrition 
bars, to ask them about their production practices. Every company listed was given the opportunity to 
share the details of their production processes with Cornucopia researchers (at a minimum, every 
company received a certified letter). Products are listed as containing "Hexane-Extracted Soy Protein" 
only when all three criteria are met: 
1. The product is not certified organic. Beware products with the claim "made with organic 
ingredients" are not certified organic, and do not display the “USDA Organic” seal. These may 
contain hexane-extracted protein ingredients. 
2. The product contains soy protein ingredients that are nearly universally processed with hexane, 
such as soy protein isolate and soy protein concentrate. 
3. The product's manufacturer or marketer did not respond to our inquiries regarding the use of 
solvents such as hexane in their processing and make no statements or representations on their 
packaging or website about going to the expense of procuring organic or conventional non-
hexane-extracted soy protein ingredients. 
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Appendix B USDA/ISU Database on Isoflavone Content of Foods 
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